Friederike Kanefendt
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 12, 2025
Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events.Ashraf Yassen, Friederike Kanefendt, Jochen Zisowsky
|Nov 07, 2024
Effect of Age, Sex, Renal Impairment and Hepatic Impairment on the Safety, Pharmacokinetics and Pharmacodynamics of Asundexian.Christine Brase, Sebastian Schmitz, Katharina Sommer
|Jul 31, 2024
Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data.Huijun Chen, Kensei Hashizume, Friederike Kanefendt
|Dec 18, 2023
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling.Friederike Kanefendt, André Dallmann, Huijun Chen
|Dec 04, 2023
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies.Friederike Kanefendt, Christine Brase, Natalia Jungmann
|Jun 26, 2023
Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans.Isabel Piel, Anna Engelen, Dieter Lang
Pageof 1
Frequent Collaborators
2 joint publications
Huijun Chen
2 joint publications
Tianxing Liu
1 joint publications
André Dallmann
1 joint publications
Sebastian Frechen
1 joint publications
Marcus-Hillert Schultze-Mosgau
1 joint publications
Kensei Hashizume
1 joint publications
Christine Brase
1 joint publications
Sebastian Schmitz
1 joint publications
Peter Vis
1 joint publications
Dirk Garmann
